Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis. | Int J Mol Sci | 2021 | 34071155 | PubTator, text mining | PubMed |
| Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis-A Pilot Study. | J Clin Med | 2021 | 34069830 | PubTator, text mining | PubMed |
| Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. | J Clin Med | 2021 | 34064035 | PubTator, text mining | PubMed |
| Association Between Myasthenia Gravis and Systemic Lupus Erythematosus as a Comorbid State. | Cureus | 2021 | 34055558 | PubTator, text mining | PubMed |
| Case Report: MDM4 Amplified in a Thymoma Patient With Autoimmune Enteropathy and Myocarditis. | Front Endocrinol (Lausanne) | 2021 | 34054730 | PubTator, text mining | PubMed |
| Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report. | J Med Case Rep | 2021 | 34053457 | PubTator, text mining | PubMed |
| Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature. | Front Neurol | 2021 | 34046006 | PubTator, text mining | PubMed |
| Effective Early Treatment of AChR Antibody-Positive Myasthenia Gravis with Rituximab; the Experience from a Neuroimmunology Clinic in a Developing Country. | J Cent Nerv Syst Dis | 2021 | 34045914 | PubTator, text mining | PubMed |
| Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita. | Neurol Neuroimmunol Neuroinflamm | 2021 | 34045306 | PubTator, text mining | PubMed |
| Membraneless condensates by Rapsn phase separation as a platform for neuromuscular junction formation. | Neuron | 2021 | 34033754 | PubTator, text mining | PubMed |
| Tonifying spleen and replenishing kidney method of traditional Chinese medicine for myasthenia gravis: A protocol for systematic review and meta-analysis. | Medicine (Baltimore) | 2021 | 34032708 | PubTator, text mining | PubMed |
| A novel DOK7 mutation causing congenital myasthenic syndrome with limb-girdle weakness: case series of three family members. | Heliyon | 2021 | 34027146 | PubTator, text mining | PubMed |
| 3D DenseNet Deep Learning Based Preoperative Computed Tomography for Detecting Myasthenia Gravis in Patients With Thymoma. | Front Oncol | 2021 | 34026611 | PubTator, text mining | PubMed |
| Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge. | Oncogene | 2021 | 34017076 | PubTator, text mining | PubMed |
| Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis. | Orphanet J Rare Dis | 2021 | 34016126 | PubTator, text mining | PubMed |
| Risk of subsequent atrial fibrillation in patients with myasthenia gravis: A population-based cohort study. | Medicine (Baltimore) | 2021 | 34011098 | PubTator, text mining | PubMed |
| The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (Review). | Exp Ther Med | 2021 | 34007311 | PubTator, text mining | PubMed |
| Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis. | Brain Commun | 2021 | 33997784 | PubTator, text mining | PubMed |
| Editorial: Structural Studies of Protein Complexes in Signaling Pathways. | Front Mol Biosci | 2021 | 33996897 | PubTator, text mining | PubMed |
| Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review. | Front Immunol | 2021 | 33995340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=61